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As the costs of health care increase, the ethical ramifications of the 
system also grow. By this I mean that as we invest larger amounts of 
resources in the delivery of health services (in both absolute dollars 
expended as well as relative to other kinds of resource development), 
the impact of the system on the lives of larger proportions of our 
population becomes more pervasive and profound. This impact occurs 
not only through obvious and direct ways such as delivering more 
health care to underserved groups or providing new services to other 
groups with consequent changes in health status,l but also there are 
less obvious effects . 
These indirect effects of our enlarging and increasingly expensive 
system may have impacts at least as important on the lives of people. 
These occur through the system's impact on the very conditions under 
which people live. This then has ethical implications for those who, at 
any level in the system, have a part in determining the size and shape 
of health care in the nation or in any given community. 
For example, we can roughly characterize our health care delivery 
system in economic terms as inherently inflationary; that is, it is both 
capital intensive (huge amounts of funds are required to develop and 
equip its organizational emphasis on inpatient facilities) and energy-
intensive in (a) the development and maintenance of its technology as 
well as (b) , its emphasis on specialized personnel, 80% of whom are 
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attached to inpatient sites. 2 The indirect impact of this kind of system 
on the lives of many communities and groups means at least the 
following: 
- To the extent that a specialized system can only be supported by 
large and relatively affluent populations, it primarily locates in 
urban and affluent communities, thereby contributing to the 
urban-rural or central city-suburban income gaps, fostering the 
decline of poor communities. 3 
- Its costliness not only diminishes direct access to services by lower 
income groups but also, because of predominant methods of financ-
ing, places a relatively greater burden on the income of those same 
poorer groups through flat rate payments such as insurance premi-
ums and social security taxes. 4 
- The specialized emphasis among health personnel, increasingly cre-
dentialed through university degrees, has the effect of favoring the 
entry, promotion, and income maintenance of those from privileged 
households and of keeping those from poorer families in the lower-
income health occupations, with fewest opportunities for further 
training or promotion. 5 
- The 140 billion dollars used by the system each year means, in 
effect, that those billions are not being used in alternative ways, 
ways which may have potentially greater positive impacts on health. 6 
In these broad ways then, the health care system as an economic 
entity affects the communities, incomes, resources, the basic condi-
tions under which large numbers of people live . To the extent that 
certain groups, especially the lower-income, rural or ghetto communi-
ties, or elders, become or are maintained as deprived groups, the 
system contributes to perpetuating their above-average burden of 
disease, and makes them more vulnerable to future illness. This is the 
basis of the ethical consequences - the impact on the chances for 
health and life of community populations - flowing from the deci-
sions which determine the size and character of our health care 
system. 
What follows is an attempt to focus these general concerns on a 
specific area of decision-making within the delivery system, namely, 
the development of screening programs. This is an area which is receiv-
ing increasing attention among community health personnel. It is a 
service component which appears to be expanding on the assumption 
that it is not characteristic of the system as a whole. In other words, it 
is relatively not expensive, is readily deployable, is often relatively 
simple and non-specialized, and is preventive in nature and thereby 
health-promoting. I am following the generally accepted definition of 
screening as "the presumptive identification of unrecognized disease 
or defect through tests, examinations, or other readily applied meas-
ures carried out on apparently well individuals." 8 Thus, screening is a 
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mode of secondary prevention in that it seeks to discover adverse 
conditions in order to prevent their extension or sequelae. 
The ethics of screening as a service per se has often been discussed 
in its non-economic dimensions. These include such important issues 
as whether to screen when treatment does not exist or is unavailable, 
or whether to inform individuals of adverse findings when available 
treatment may be ineffective. Rather clear-cut criteria have been 
recently developed and widely discussed for guiding decisions on the 
use of screening.9 
Ethical Aspects of Economics 
Here our discussion will focus on the ethical aspects of the econ-
omics of screening programs. In order to examine this dimension some 
basic questions must be addressed: 
1. What is the efficacy of screening? That is, what is the usefulness 
to the individual of the service rendered? Is the screening tool 
able to detect disease or defect? 
2. What is the effectiveness of screening? What health-promoting 
impact is it actually having on a given population, and the related 
prior question, is it reaching the appropriate population? 
3. What is the efficiency of screening measured in cost-effectiveness 
relative to other means of discovering illness, and/or measured in 
cost-benefits , the dollar-value of savings in treatment and time 
lost from consumers' daily activities? 
Although the answers to these questions are only beginning to be 
developed, there are available several efforts to summarize findings in 
response to one or more of them, concerning either the efficacy, 
effectiveness, HEW/Congress, or efficiency of screening programs. 10 
The following discussion seeks to combine these interrelated aspects 
of screening services in order to draw out the ethical implications 
inherent in decisions to develop or expand these programs. 
The most common screening techniques are of course the physical 
examination and various kinds of biochemical or other tests. These 
may be multiphasic or disease-specific. An analysis of what is known 
about the efficacy of these techniques for a variety of age groups has 
been made. 11 
Some generalizations which may be drawn from the data are: 
1. Routine physical examinations for children are not an efficient 
means for discovering significant adverse conditions which are 
not already known by the child's caretakers or which could not 
have been detected by other means; this method is somewhat 
more efficient for children from poor families who have no regu-
lar source of care (e.g., migrant workers' families). 
2. Multiphasic screening produces a low yield of new findings in 
general popUlations; it is somewhat more efficient among se-
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lected, high-risk groups such as lower income and black popula-
tions. The types of new diagnoses are relatively few and non-
complex, such as hypercholesterolemia and iron deficiency 
anemia, especially among the poor. Although large proportions 
of the tests show "abnormal" results, these are non-diagnostic 
and their significance if any is not known. Such screening is 
cost-effective only among client populations of 15,000 children 
or 24,000 adults or more per year. 12 They have been shown to 
alter morbidity only rarely, as among middle-aged men through 
deferring death from cardiovascular disease and cancer.l3 
3. Routine disease-specific screening in infants and children, 
whether by physical examination or laboratory tests, has yielded 
low positive findings, often with a high proportion of false posi-
tives. Results are more efficient in selected high risk groups such 
as families already known to have had children with birth anom-
alies. Congenital orthopedic problems are the most treatable. For 
many others, such as the metabolic diseases, treatment is pal-
liative. PKU, for which appropriate treatment is effective, is cost-
beneficial because of the life-long care required for its sequela of 
mental retardation. However, as has been shown, the screening 
procedure as done in the U.S. is not optimally-timed, thus missing 
some children who are thereby lost to preventive treatment. 14 
4. Screening for many growth and development variations in chil-
dren has a very high risk of false positives among large propor-
tions of children screened, without evidence that such findings 
have any positive health effects. These measurements include 
elevated blood pressure, anemia after age one, intestinal parasites, 
and non-toxic blood lead levels; there is no evidence that medical 
treatment, e.g., iron supplements, will alter the health and disease 
patterns of these children. However, selective screening and inter-
vention for dental, tubercular, and venereal diseases will alter the 
course of illness. 
5. The methods for mass, disease-specific screening in adults are 
generally efficacious, i.e., they can detect underlying illness for 
serious health problems, such as chronic lung disease, hyperten-
sion, and certain cancers. However, such methods are often not 
effective for changing the course of illness among populations 
because, as in the case of chronic lung disease or lung cancer, 
treatment is palliative and does not apparently deter progression 
of the disease. Or, as with hypertension, non-symptomatic patients 
tend not to seek treatment or to be given treatment by their 
physicians. 15 Or, again, there is question whether the findings 
signify incipient illness at all , such as some bacterurias, anemias, 
and hyperglycemia. 
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There is also question as to what positive health effects are 
possible from uterine and breast cancer screening except among 
selected age groups; that is, at what point is screening costing 
more than what is saved in lives and treatment costs? One study 
showed that for the 23 women whose deaths from breast cancer 
were deferred through early detection and treatment in a five 
year screening program, the same effect could have been 
obtained through a program for smoking prevention; for it is 
likely that about 23 of the 31,000 screened women died of lung 
cancer during that period. 16 
Effectiveness of Screening Techniques 
Clearly, efficacious screening techniques (i.e., those which can pro-
duce a high yield of true positives and low yield of false negatives) 
become effective (i.e., make a measurable difference in the health of 
populations) when they detect conditions which can be contained or 
cured by available treatment. This implies that these screening proc-
esses will be more efficient in relation to funds expected when the 
screening procedure is focused on selected, high-risk groups as com-
pared with mass or otherwise haphazard programs in the general popu-
lation. 
However, the record of effectiveness for even efficacious screening 
techniques has been limited. They have not succeeded in reaching the 
appropriate groups even when the stated purpose was to focus on 
selected populations-those groups more likely to be vulnerable to 
particular illnesses or abnormalities because of familiar traits, age, sex, 
or socio-economic deprivation. Large proportions of such populations 
r~main untested. Table 1 illustrates the ineffectiveness of the seg-
mented Medicaid approach to screening as well as the greater effective-
ness that concerted follow-up efforts can have for cervical screening. 
In large part, high-yielding, efficacious screening techniques are 
limited in their effectiveness, even when properly focused on high-risk 
groups, because they are generally segregated from follow-up and 
treatment programs. The burden of obtaining appropriate confirma-
tion and treatment falls on the consumer. This is particularly difficult 
for those most likely to require treatment and least able to seek it due 
to the press of day-to-day problems, as experienced by low-income 
people. Their access to health services, even to programs specifically 
intended to reach them, is made difficult because the system has not 
effectively reached them as Table 2 illustrates. 
Ambulatory care has reached only small proportions of low income 
groups, those most vulnerable to illness. Thus, even accurate screening 
and efficacious forms of treatment cannot be · effective in terms of 
improving the outcomes in health for those populations. Too often, of 
course, diagnosing and treating individuals' illnesses does little to 
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improve the incidence and prevalence of symptoms which result from 
poor living conditions (Table 2). 
The problem of access is compounded by the ineffectiveness of 
financing programs. Medicaid covers somewhat over half of low-
income families only, and pays no more than two-thirds of their 
health care expenditures. 
To reiterate the basic ethical question inherent in the economics of 
screening programs : is the expenditure of resources, funds, personnel, 
and agency capability justified when such programs cannot make a 
measurable positive impact on the health of a given population? The 
reasons why screening may not be capable of health-promoting 
impacts include: 
- the technology is not efficacious in specificity or sensitivity; 
- the health problem is ill-defined, rare, self-limiting or untreatable; 
- the delivery of the screening program is not directed to high-risk 
populations or is not effective in reaching those groups; 
- confirmation of and treatment for positive findings are not assured 
through integration with effective services delivery and financing 
programs. 
To purposefully develop screening programs when they cannot 
produce positive health impacts for one or more of these reasons has, 
in tum, an indirect and negative impact on the health of the consumer 
population in question. It means that the funds so expended, while 
surely paying the costs of the health agency, are not being spent for 
programs which do have potential for healthful results among the 
population. 
In other words, given limited resources, to what alternative uses can 
screening funds be put when all of the criteria for a justifiable screen-
ing program cannot be met? 
It is conceivable that with comparable resources, alternative pro-
grams in primary prevention might be developed or strengthened in 
place of the effort at secondary prevention which screening programs 
represent. For example, with due regard for the particular problems of 
a given community, monies for child health might be used to provide a 
truly effective immunization program, the efficacy of which is well 
proven, but the effectiveness of which has been limited because of 
inadequate outreach (Table 3). Concern over birth abnormalities 
might alternatively be dealt with through efficacious technologies of 
birth control techniques or food for poor women, both highly effec-
tive for healthful outcomes when effectively delivered (Tables 1 and 
4). Again, whereas more high-lead blood levels are being found in lead 
screening programs, the proportion of housing found with hazardous 
lead paint has not changed. 17 Reducing such dangerous living condi-
tions would be more cost-effective for the health of children in many 
communities. 
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When health care resources are used without known positive effects 
on the health of community populations, they are not only wasted, but 
also may have measurable , negative effects, directly, in absorbing con-
sumers' time, causing concern and inconvenience, incurring out-of-
pocket costs. And as importantly, the indirect impact is to deprive 
them of potentially more-health-promoting uses of those resources. 
The heightening of our awareness of this reality should imply that 
program development requires thoughtful analysis before we dare rush 
in with the somewhat faddish nature of new or revived service activi-
ties. The total picture needs viewing, with assessment made of the 
relative impacts of alternative programs and strategies. 
One way to do this is through working with the new health systems 
agencies, with their developing areawide data-gathering capability. 
Becoming acquainted with the growing literature on what "works" in 
health services is also essential. Furthermore, developing alternative 
and more healthful uses of community resources is further best done 
in concert with concerned others, including human services and 
environmental groups, and not least, community organizations and 
representative consumers. 
With these inputs, the size and shape of health care in given com-
munities would be different from what we know now, and might 
indeed impact more healthfully on people's lives. 
REFERENCES 
1. Mil io, N., "Environment, Healt h , and Health Services: A T eaching-Learning 
Tool, " Nursing Outlook, April, 197 6. 
2. Milio, N. , The Care of Health in Communities: Access for Outcasts (New 
York: Macmillan Co., 1975), ch ap. 6. 
3. Op. cit., ch ap. 3. 
4. Op. cit., ch aps. 3, 5. 
5. Op. cit., ch ap. 6. 
6. Op cit., chaps. 9, 10. R. Gibson and M. Mueller, "National Health Expendi-
ture Highlights , Fiscal Year 1976," R esearch and Statis tics Note 27 (Dec. 22, 
1976). N. Milio, "Health Po licy and Wom en 's Health, " Health Care Manage ment 
Review, April , 1977. 
7. Milio, N., "A Framework for Prevention: Ch anging Health-Damaging to 
Health-Generating Life Patterns," A merican Journal of Public Health, May, 1976. 
8. Whi tby, L. , "Screening for Disease," Lancet, Oct. 15,1974, pp. 819-22_ 
9. Conference Report, National Conference on Preventive Medicine, June 7-9 , 
1975, National Institutes of Health and American College of Preventive Medicine , 
Washington, D.C. See also Appendix of th is article. 
10. Rutstein, D. , et_ al., "Measuring th e Quality of Medical Care," New Eng-
land Journal of Medicine 294 (1976), pp. 582-588 . C. Bombardier, et.al., "Period-
ic Health Examinations and Periodic Screening," Canadian Medical Assoc. Journal 
109 (December, 1973), pp. 1123-1126. D. Louria, et. al., "Primary and Secondary 
Prevention Among Adults: An Analysis and Comments on Screening and Health 
Education," Preventive Medicine 5 (1976), pp. 549-572. "Screening for Disease," 
Lancet, series from October 15 to December 15,1974 . A. F. North, "Screening 
November, 1977 353 
in Child Health : Where Are We Now and Where Are We Going?" Pediatrics 54 
(November, 1974), p . 5. P. Frame and S. Carlson, "A Critical Review of Periodic 
Health Screening Using Specific Screening Criteria," parts HV, Journal of Family 
Practice 2: nos. 1-4 (1975). 
11. Based on materials from N_ Milio, Health Planning and Administration with 
the Consumer in View and Involved, Unit II : Analyzing and Evaluating Health 
Planning Data for its Impact on Consumers prepared for the Program in Commun-
ity Health Planning and Administration, College of Community Services, Univer-
sity of Cincinnati with the aid of Contract No. N01-MB-44178, Bureau Health 
Research and Development Health Resources Administration, DHEW, December, 
1976. 
12_ Collen, M., et. al., "Cost Analysis of Multiphasic Screening Programs," New 
England Journal of Medicine 280 (1969), pp. 1043-45. W. Frankenburg, "Selec-
tion of Diseases and Tests in Pediatric Screening," Pediatrics 54 (November, 
1974), p. 5. 
13. Dales, L., et. al., "Multiphasic Check-Up Evaluation Study," Preventive 
Medicine 2 (1973), pp. 221-35 . 
14. Starfield, B., and Holtzman, N., "A Comparison of the Effectiveness of 
Screening for PKU in the U.S ., United Kingdom, and Ireland, " New England 
Journal of Medicine 293 (1975), pp. 118-21. 
15. Sacket, D., "Screening for Disease: Cardiovascular Diseases," Lancet, Nov. 
16, 1974,p~ 1189~1 . 
16. Cairns, J., "The Cancer Problem," Scientific American, November, 1975, 
pp.64-78 . 
17. Center for Disease Control, "Lead Screening," Morbidity and Mortality 
Weekly Report, Feb. 11, 1977. 
Table 1 
The Effectiveness of Personal Health Services in Secondary Prevention: 
Delivery of Screening Programs 
Effectiveness: % of Target 
Screening Programs Population Reached 
Early & Periodic Screening, Diagnosis & 14.8% screened 
Treatment (Medicaid), 1975 1 60.4% of ill treated 
Pap smears , annual teaching hospital clinic 2 25% 
Group practice with mailed reminders 2 48% 
Follow-up for positive (cancerous) findings 3 88 % 
REFERENCES 
1. House Subcommittee on Oversight and Investigations, Getting Ready for 
National Health Insurance, Hearings, Oct. 8, 1975 (Washington, D.C.: House of 
Rep. Committee on Commerce, 1975). 
2. Lewis, E., "Consumer Control of Carcinoma of the Cervix," American 
Journal of Obstetrics and Gynecology 119 (1974), pp. 669-674. 
3. Family Planning Perspectives 7 (March-April, 1975), pp. 60-61. 
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Table 2 
The Effectiveness and Efficiency of Personal Health Services 
in Secondary Prevention: Delivery of Ambulatory Services 
EFFECTIVENESS 
% of Target 
Population 
Reached Health Outcomes 
AMBULATOR Y CARE TO POOR a, 1, 2 
Neighborhood 
health centers 
(314e & OEO) 
Maternity and 
infant projects 
Children and 
youth projects 
Free clinics 3 
Migrant health 
centers 4 
2-25 % 
0.6-19 
1.8-13 
2.0-25 
? 
Est. 10% drop in infant 
deaths 1965-70. (20 deaths 
prevented per 1000 
births) ;6 little change in 
prematurity rates. 
No measurable 
improvement. 
FAMILY 
PLANNING 
SERVICES5 
62 Est. 27% drop in infant 
(rural : 48%) deaths, 1965-70 6 
clinics, 32 
Free-standing ;> 
General care clinics ( rural : 19% ) 
Hospital-based 
Private MD office 30 
(rural:29%) 
PREPAID GROUP PRACTICE 7 
Physicians only 
Nurse practitioner 
& automated 
screening 
20xnew 
entrants/y r. 
PREPAID GROUP PRACTICES (1971)8 
0.05 % (of 
poor) 
M.D. 
Visits 
EFFICIENCY 
Cost/Effectiveness 
Estimates 
Some reduction in 
hospital adm issions 
& eme rgency 
outpatient visits, 
$150-450/clinic session 
($200/session) 
Avg. $61,000/yr. project 
81 % allocated to medical 
services 
29% of total to hospitals 
$135,000/ project 
$61 / pt. /y r. (1971) 
$69 / ptJyr . (1971) 
$55/pt./yr. (1971) 
$24/ptJy r. (1971) 
$96/ pt. /yr . . 
$131 /ptJy r. 
$ 98 /ptJyr_ 
ANNUAL 
Hospital adm. 
(perl 000 pop. ) Cost/pt. 
Low income 
enrollees 
All other 
enrollees 
6% (of U.S. 
population) 
Compared w /other 
delivery models: 10 
Death rate of elders 
11 % lower ; infant 
deaths 17-23% 
lower. 
3.9-4 .0 60-iol $75 ( low 
(low inc . ) income) (low inc.) 
4.2 (other 
income) 
(U.S. avg.: 
4.5 visits) 
ADULT AMBULATORY CARE 1969-72 9 
Low-income 60-72 (% w/ 
symptoms) 
Above-average 62-72 (% w/ 
income symptoms) 
Symptom prevalence 
unchanged: higher for 
poorer, lower for non-poor 
CHILDHOOD AMBULATORY CARE 1969-72 
Low-income 
Above-average 
income 
70-74 (% w/ 
symptoms) 
74-85 (% w/ 
symptoms) 
Symptom prevalence 
unchanged: roughly 
similar for both groups , 
poor about the same as 
non-poor. 
a=poverty level to 200% above designated poverty level. 
November, 1977 
73-92 $47 (other 
(other inc.) income) 
145 adms. 
(U.S. avg.) 
355 
TABLE 2 
REFERENCES 
1. Morten, W., and Northman, S., "Neighborhood Health Center Experience," 
American Journal of Public Health 65 (March, 1975), pp. 248·52. 
2. Komaroff, A. and Duffell, P., "An Evaluation of Selected Federal Categori-
cal Health Programs for the Poor," American Journal of Public Health 66 (March, 
1976), pp. 255-56. 
3. Tennant, F ., and Day, C., "Survival Potential and Quality of Care Among 
Free Clinics," Public Health Reports 89 (Nov.-Dec., 1974), pp. 558-62. 
4. Shenkin, B., Health Care for Migrant Workers: Policies and Politics (Cam-
bridge : Ballinger, 1974). 
5. "Program Evaluations," Family Planning Digest 3 (January, 1974), p. 13. M. 
Carey, "US Organized Family Planning Programs in FY 1974," Family Planning 
Perspectives 7 (May-June, 1975), pp. 98-103. 
6. Morris, N., et. al., "Shift Age-Parity Distribution of Births and the Decrease 
in Infant Mortality," American Journal of Public Health 65 (April, 1965), pp. 
359-62. M. Terris and M. Glasser, "A Life Table Analysis of the Relation of 
Prenatal Care to Prematurity," American Journal of Public Health 64 (September, 
1974), pp. 869-75. M. Kauffman and A. Cunningham;"Epidemiologic Analysis of 
Outcomes in Maternal and Infant Health in Evaluating the Effectiveness of Three 
Patient Care Teams," American Journal of Public Health 60 (September, 1970), 
pp. 1712-25. 
7. Garfield, S., et. al., "Evaluation of an Ambulatory Medical-Care Delivery 
System," New England Journal of Medicine 294 (1976), pp. 426-31. 
8. Sparer, G., and Anderson, A., "Utilization arid Cost Experience of Low-
Income Families in Four Prepaid Group Practice Plans ," New England Journal of 
Medicine 289 (July 2, 1973), pp . 67-72. C. Gans, et. al., "HMO Evaluation: 
Utilization Before and After Enrollment," paper, APHA, Nov. 15, 1972. Social 
Security Administration, "Independent Health Insurance Plans in 1972," Residen-
tial and Statistical Notes, May 3,1974. 
9. McDonald, A. , et. al., "Effects of Quebec Medicare on Physician Consulta-
tion for Selected Symptoms," New England Journal of Medicine 29 (Sept. 20, 
1974), pp. 649-52. 
10. Bureau of Health Planning and Resources Development, Trends Affecting 
the U.S. Health Care System (Rockville, Md.: HEW, HRA, 1976), p. 232. 
356 Linacre Quarterly 
Table 3 
The Efficacy, Effectiveness, & Efficiency 
of Personal Health Service for Primary Prevention of Disease: 
1974 
Polio 
(3 doses +)1 
DTP 
(3 doses+)l 
Measles 2 
Rubella 3 
Smallpox 4 
905 
Immunizations & Fluoride 
63.1 60 68 .1 
73.9 69.5 77.9 
64.5 62.5 68 .5 
59.8 6l.1 62.3 
47 66.2 
59.4 74.3 
1 life saved/ 
10,000 cases; 
1 MR saved / 
3,000 cases. 
$3/patient; 
$6 million 
for all 2-yr. 
olds. 
Net benefits: 
(saved treatment, 
long-term care, 
2400 lives saved) 
$l.3 billion. 
$38.5 million ($1 
in costs to 8 in 
benefits) savings 
on complications 
of congenital 
rubella in 
newborn, care of 
retarded, loss of 
life-long . 
productivity, etc. 
$2.20 costs to $1 
in benefits 
(treatments 
saved). 
* Vaccines also exist to prevent typhoid fever, yellow fever, epidemic typhus, Rocky 
Mountain spotted fever, tuberculosis, meningitis , mumps, some influenza. 
** For a discussion of financial and geographic access to health care, see N. Milio, Care 
of Health in Communities: Access for Outcasts (New York: Macmillan, 1975), 
chaps. 3-5. 
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Table 4 
Improving Mothers' and Children's Health Relative Benefits 
From Selective Approaches, 1960-1970 Data 
APPROACHES ESTIMATE OF BENEFITS 
Improving women's nutrition, Reduction in infant deaths by 50%. 
quantity & quality , before Reduction in maternal deaths by 50%. 
& during pregnancy. Improved child nutrition & decrease in 
infections & deaths by 90%, age 1-4. 
Lengthening and spacing birth Reduction in infant deaths by 30%. 
intervals between age 20-34. Improved child nutri t ion. 
Decreasing number of Reduction in infant deaths by 10%. 
pregnancies to 3 or fewer. Improved child nutrition. 
Stnpping smoking before and Improved maternal health. 
during pregnancy. Addition of % to '/. lb . to infant, 
avoid ing low birth weight. 
Prenata l care to " high-risk" Less than 10% reduction in infant 
women. deaths. 
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APPENDIX 
Summary of Recommendations for Screening* 
Criteria for Evaluation of Screening Programs 
l.Screening must lead to an improvement in end-results (defined in terms of 
mortality; physical , social and emotional function; pain; and satisfaction) 
among those in whom early diagnosis is achieved or in the other members of 
the community_ 
a_ The therapy for the condition must favorably alter its natural history, not 
simply by advancing the point in time at which diagnosis occurs, but by 
improving survival, function or both_ The modification of "risk factors" is 
not sufficient evidence of effectiveness, nor is the fact that the proposed 
therapy is "commonly accepted." Claims for therapeutic effectiveness must 
withstand rigorous methodologic scrutiny, and experimental evidence, such 
as controlled clinical trials, is a prerequisite. The measurement of survival and 
other end-results must withstand epidemiologic and biostatistical scrutiny . 
Disease should have a recognizable, latent (asymptomatic) stage. Screening 
should be a continuous (not one-shot) process. Abnormality to be screened 
should be precisely defined. 
b. Available health services must be sufficient both to ensure diagnostic con-
firmation among those whose screening is positive and to provide long-term 
care. 
c . Compliance among asymptomatic patients in whom an early diagnosis has 
been achieved must be at a level to be effective in altering the natural history 
of the disease in question. 
d. The long-te rm beneficial effects, in terms of end-results, must outweigh the 
long-term detrimental effects of the therapeutic regimen utilized and the 
"labelling" of an individual as "diseased " or "high risk." 
2.The effectiveness of potential components of multiphasic screening should be 
demonstrated individually prior to their combination. 
3.If the benefits of screening accrue to the community at large rather than, or in 
addition to, the individual identified (e. g. , disease carriers, specific occupa-
tions), the community benefit claimed must withstand scientific scrutiny . 
a. The appropriateness of the mix of screening tests to the target population 
must be conside red, acknowledging that differences in the distribution of 
two diseases may render the combination of their respective screening tests 
inappropriate. 
4.The cost-benefit and cost-effectiveness characteristics of mass screening and 
long-term therapy must be known. This knowledge is considered essential in 
developing an appropriate mix of diagnostic and therapeutic services in the face 
of finite manpower and financial resources. Therefore, a mechanism for the 
formal periodic weighing of costs against benefits or effec tiveness should consti-
tute a bas ic component of the ini tial screening activities. 
5. The burden of disab ility for the condition in qu est ion (in terms of disease 
frequency, distribution, severity, and alternative approaches to its detection 
and control) must warrant action. 
6.The cost , sensitivity, specificity, and acceptability of the screening test must be 
known, and it should lend itself to the utili zation patterns of the target popula-
*Source: National Conference on Preventive Medicine papers, June 7-9 , 1975, 
Washington , D.C., NIH-ACPM. 
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tion. Comparison should be mad e with previous preve ntion and treatment 
methods and other alternatives in order to determine the relative efficacy and 
cost· effectiveness of the proposed test. 
7.Ideally , an estimate of the social benefit of preventing, arresting, or curing the 
condition in question should be known . Difficulties of widespread implementa-
tion should be studied. "Borderline findings should h ave a policy ." 
Validation of Screening Test Methods 
1. Simplicity . In many screening program s more than one test is used to detect one 
disease, and in a multiphasic program the individual will be subjected to a 
number of tes ts within a sh o rt space of time. It is therefore essential that the 
tests used should be easy to administer and should be capable of use by para-
m edical and other perso nnel. 
2.Acceptability. As screening is in most instances voluntary and a high rate of 
cooperation is necessary in an effic ient screening program , it is imp ortant that 
tests should be acceptable to th e subjects. 
3.Accuracy. The test should give a tru e measurement of the att ribute under in-
vestigation. 
4. Cost. The ex pense of sc reening should be considered in relation to the benefits 
resulting from the ea rly detect ion of disease, i. e ., th e sever ity of the disease, t he 
advantages of treatm en t at an ea rly stage, and the probability of cure. 
5. (Prec ision (so metimes called repeatability). The test sh o uld give co nsistent results 
in repeated trials. 
6. Sensitivity. This m ay be defined as the ability of th e tes t to give a positive 
finding when the individual screened h as the disease or abnorm ality under 
investigation. 
7 . Sp ecifici ty. This m ay be defined as the ability of the test to give a negative 
finding when the individual does not have the di sease or abnorm ali ty under 
investigatio n. 
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